Clinical Trials Browser

Phase 2 × INDUSTRY × balugrastim × Clear all

NCT01940601 2015-01-14

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors